GLP-1 receptor agonists, such as semaglutide, are a class of medications commonly prescribed for managing type 2 diabetes and obesity
Our research library covers reconstitution and concentration calculations for in-vitro work.
This is thought to be related to GLP-1s effects on the brains dopamine reward pathway, says Nitya Kumar, MD, an endocrinologist and an assistant professor of medicine at the Duke University School of Medicine in Durham, North Carolina
Tools for tracking your GLP-1 timeline Tracking your progress systematically helps you understand your personal response curve and identify what is working
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
For seniors and Americans with long-term disabilities struggling against obesity and related health problems, this is good news